SSTR5 and acromegaly: In acromegaly patients resistant to octreotide, tumors lacking SST5 immunoreactivity were resistant to pasireotide, whereas those with SST5 staining using the rabbit mAb UMB-4 had superior biochemical response (Iacovazzo et al., 2016).